# Gynecologic Oncology Referral

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Gwen Ifill (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML032-SYN-TD
- Date: 2016-01-05
- Fictional facility: St. Posthumous Health Center
- Fictional author: Lorna Achebe-Price, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- To: Miriam Delacroix, MD, Gynecologic Oncology
- Urgency: Within two weeks; sooner if the biopsy shows cancer

## Referral question

Postmenopausal bleeding for three weeks in a 60-year-old journalist, about eight years after her last period and with no hormone use. An office endometrial biopsy was taken today and a transvaginal ultrasound is booked this week. Please see her within two weeks to review both results with her and plan treatment if they show cancer or atypical hyperplasia. **S**

## Questions for the consultant

1. If the biopsy shows cancer, what are the histology, grade, molecular class and stage, and what further staging is needed?
2. What surgery do you recommend, including how the lymph nodes should be assessed?
3. Which treatment after surgery would the final stage and molecular class call for?
4. How should Lynch syndrome be screened for, and does she or her blood relatives need genetic testing?
5. What monitoring should primary care share during and after treatment?

## Pertinent history

Spotting, then light bleeding on and off for about three weeks, without pain; last period about eight years ago; no menopausal hormone therapy or tamoxifen. No children. Never smoker. Examination today with a chaperone: blood at the cervical os, normal cervix, uterus mobile and of about normal size, no adnexal mass. Office endometrial biopsy taken today with adequate tissue. Results today: hemoglobin 11.8 g/dL, platelets 268, creatinine 0.82 mg/dL, glucose 94 mg/dL, A1c 5.5%. BMI 27.4. PHQ-2 negative. No medicines; no known allergies. She wants the cause found quickly and told plainly, and she wants her health information shared only with the clinicians caring for her. **S**

- Gwendolyn Ifill was born in Queens, New York, on September 29, 1955, the fifth of six children. Her father, a Panamanian immigrant, became a pastor in the African Methodist Episcopal Church; her mother was from Barbados. The family moved around the Northeast for her father's work and for a time lived in federally subsidized housing. **D**
- She graduated from Simmons College in Boston in 1977. As a college intern at the Boston Herald American she found a racist note left for her; the paper's editors hired her after she graduated. She went on to report for the Baltimore Evening Sun, The Washington Post, The New York Times and NBC News. **D**
- In 1999 she became moderator of PBS's Washington Week in Review, the first African American woman to host a major national political talk show, and a senior correspondent for the NewsHour. In 2013 she and Judy Woodruff were named co-anchors of the PBS NewsHour, the first women to jointly lead a national nightly news broadcast. **D**
- She moderated the vice-presidential debates of 2004 and 2008. In the 2004 debate she asked the candidates about AIDS in the United States, citing the much higher death rate among Black women aged 25 to 44. She wrote The Breakthrough: Politics and Race in the Age of Obama (2009). **D**

3 later historical claims are omitted because they describe events after the index age. See the teaching note.

Baseline: Hemoglobin: 11.8 g/dL (low); White cell count: 6.2 10*3/uL; Platelets: 268 10*3/uL; Creatinine: 0.82 mg/dL; eGFR (CKD-EPI 2011): 82 mL/min/1.73 m²; Glucose: 94 mg/dL; Hemoglobin A1c: 5.5%; PHQ-2: 1. All results are synthetic.

BP 128/80 mmHg; pulse 78 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 99% on room air; weight 74.6 kg; BMI 27.4 kg/m². All vital signs are synthetic.

## Current medications

- No current medications. **S**

## Plan so far

- Any bleeding after menopause is evaluated: speculum and bimanual examination, office endometrial biopsy at the first visit, and transvaginal ultrasound within the week, both done rather than relying on endometrial thickness alone; blood count and A1c; results by telephone within days, not at a routine visit. Guideline: Updated Guidance Regarding the Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Individuals With Postmenopausal Bleeding. Obstet Gynecol 2026;148(1):e87-e91 (PMID 41990335) (2026); Committee Opinion No. 734: The Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Women With Postmenopausal Bleeding. Obstet Gynecol 2018;131(5):e124-e129 (PMID 29683909) (2018); Clarke MA, et al. Racial and Ethnic Differences in Hysterectomy-Corrected Uterine Corpus Cancer Mortality by Stage and Histologic Subtype. JAMA Oncol 2022;8(6):895-903 (PMID 35511145) (2022); Doll KM, et al. Assessment of Prediagnostic Experiences of Black Women With Endometrial Cancer in the United States. JAMA Netw Open 2020;3(5):e204954 (PMID 32412636) (2020) **S**
- Distress and depression screening at each visit, plain explanations, written information, and support she chooses; she decides who receives each note. Guideline: NCCN Clinical Practice Guidelines in Oncology: Uterine Neoplasms (2026); Depression and Suicide Risk in Adults: Screening (2023) **S**
